title: Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome.
authors: Vittorio
authors: V
authors: Perfetti
authors: Giovanni
authors: G
authors: Palladini
authors: Mara
authors: M
authors: De Amici
authors: Luca
authors: L
authors: Livraghi
authors: Paolo
authors: P
authors: Pedrazzoli
authors: Giampaolo
authors: G
authors: Merlini
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D004351:Drug Resistance; D017809:Fatal Outcome; D006801:Humans; D016878:POEMS Syndrome / Q000188:drug therapy*; D012008:Recurrence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab